| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/10/2008 | WO2008042420A2 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders |
| 04/10/2008 | WO2008041665A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 04/10/2008 | WO2007110628A3 Compositions and methods for therapy of cystic fibrosis |
| 04/10/2008 | WO2007096382A3 Method for production of a transformed cell |
| 04/10/2008 | US20080085995 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/10/2008 | US20080085853 nuclear delivery construct comprises (i) protein H or a fragment or derivative thereof that is capable of being targeted to the nucleus of a eukaryotic cell; |
| 04/10/2008 | US20080085545 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/10/2008 | US20080085266 Using cancer antigen 125 as tool in generating transmembrane serine protease inhibitory compound for treatment of urogenital cell proliferative disorders |
| 04/10/2008 | US20080085265 System for optical stimulation of target cells |
| 04/10/2008 | US20080085264 Targeting progenitor cells to bone marrow for prevention and treatment of cell proliferative disorders; regenerative medicine and tissue engineering |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | DE10066235B4 Targeted inhibition of gene expression by administration of double stranded oligoribonucleotide to a cell, useful for treating humans, animals and plants against viral infection |
| 04/09/2008 | EP1908844A1 Use of pol III promoters for controlled expression of therapeutic proteins |
| 04/09/2008 | EP1908834A2 Heteromultimeric ion channel receptor and uses thereof |
| 04/09/2008 | EP1908830A1 Non-human gene-disrupted animal having adam11 gene disruption |
| 04/09/2008 | EP1908826A1 Prostate cancer related protein derived peptide which is a peptide vaccine candidate for prostate cancer patients with hla-a3 supertype alleles |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
| 04/09/2008 | EP1907582A2 Method of diagnosing esophageal cancer |
| 04/09/2008 | EP1907551A1 Compositions and methods comprising stinging capsules/cells for delivering a biologically active agent into a plant cell |
| 04/09/2008 | EP1907016A2 Methods and composition for modulating foxo1 activity and insulin signaling |
| 04/09/2008 | EP1907015A2 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 04/09/2008 | EP1907014A2 Chondrogenic compositions and methods of use |
| 04/09/2008 | EP1906976A2 Therapeutic polymers and methods of use |
| 04/09/2008 | EP1670919B1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/09/2008 | EP1228095B1 Modified gp100 and uses thereof |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | EP1156833B1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1100892B1 Use of prohibitin rna in treatment of cancer |
| 04/09/2008 | EP1027440B1 Inhibitor protein of the wnt signal pathway |
| 04/09/2008 | EP0972028B1 Mutants of vascular endothelial growth factor c (vegf-c) and uses thereof |
| 04/09/2008 | CN101160139A Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2 |
| 04/09/2008 | CN101160138A RNAi抑制CTGF用于治疗眼科疾病 RNAi inhibition of CTGF for the treatment of ophthalmic diseases |
| 04/09/2008 | CN101160055A Lentiviral vectors and their use |
| 04/09/2008 | CN101157919A Mammalian cell rep expression plasmid p5RCM1 and preparation method and application thereof |
| 04/09/2008 | CN100379759C Compounds for treatment of infectious and immune system disorders and method for their use |
| 04/09/2008 | CN100379758C Streptococcus pneumoniae antigens |
| 04/09/2008 | CN100379752C Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2008 | CN100379751C Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 04/09/2008 | CN100379458C Gene transfer methods |
| 04/08/2008 | US7355035 Catalytic molecules |
| 04/08/2008 | US7355025 Marker molecules associated with lung tumors |
| 04/08/2008 | US7355024 Regulatory sequences for modulation of INGAP expression and reporter constructs |
| 04/08/2008 | US7355017 Fusion polypeptide for use in the treatment and prevention of graft rejection |
| 04/08/2008 | US7354908 Materials and methods for prevention and treatment of RNA viral diseases |
| 04/08/2008 | US7354907 immunomer comprising two or more oligonucleotide branches linked together; can cause immune stimulation across species lines; less expensive to make |
| 04/08/2008 | US7354898 Identifying agents which modify mitogen activated kinase activities associated with cell death; small interfering RNA and treament of cell proliferative disorders; for modulating diseases and conditions associated with elevated or decreased apoptosis |
| 04/08/2008 | US7354762 Transfecting with an expression vector containing DNA construct encoding chimeric receptor; electroporation; use in immunotherapy and treatment of neuroblastoma |
| 04/08/2008 | US7354759 Induce immunology response; antiproliferation agents; coding immoglobulins |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354709 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer |
| 04/08/2008 | US7354594 Merozoite surface protein 1 lacking glycosylation sites |
| 04/08/2008 | US7354592 Administering mutant Salmonella sp. for therapy of solid tumor cancer, disrupted msbB gene and is capable of targeting a solid tumor cancer |
| 04/08/2008 | US7354591 Poxvirus with targeted infection specificity |
| 04/08/2008 | US7354576 Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase |
| 04/03/2008 | WO2008040017A2 Eukaryotic cells expressing (sid-i) for gene screening |
| 04/03/2008 | WO2008039980A2 Apoptotic cell-mediated transfection of mammalian cells with interfering rna |
| 04/03/2008 | WO2008038832A1 Therapeutic agent, detection method and detection kit for breast cancer and ovarian cancer |
| 04/03/2008 | WO2008038394A1 Musclin receptor and use thereof |
| 04/03/2008 | WO2008038267A2 Use of antisense oligonucleotides against cpla2 in the treatment of cancer |
| 04/03/2008 | WO2007070709A3 Skeletal site -specific characterization of orofacial and iliac crest human bone marrow tromal cells in same individuals |
| 04/03/2008 | WO2005004794A3 Method of treating neurodegenerative disease |
| 04/03/2008 | US20080081795 Suppression of nuclear factor-kappaB dependent processes using oligonucleotides |
| 04/03/2008 | US20080081792 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders, tumor or cancer; antisense agents; gene expression inhibition |
| 04/03/2008 | US20080081366 Polynucleotide composition, method of preparation, and use thereof |
| 04/03/2008 | US20080081337 Using beta -cell specific insulin gene transcription factor (MafA) as diagnostic tool for identifying insulin producing cells |
| 04/03/2008 | US20080081065 Materials and methods for inhibiting wip1 |
| 04/03/2008 | US20080081032 Using reovirus construct as therapeutic tool to decrease pain associated with treatment of cell proliferative disorders |
| 04/02/2008 | EP1905837A1 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/02/2008 | EP1905834A2 Virulence Genes, Proteins, and their Use |
| 04/02/2008 | EP1905831A2 Lactoferrin receptor genes of moraxella |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905457A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/02/2008 | EP1905304A2 Treatment of neoplasms with viruses |
| 04/02/2008 | EP1904113A2 Neuroprotective effective compound |
| 04/02/2008 | EP1904112A2 Herpes virus-based compositions and methods of use |
| 04/02/2008 | EP1904110A1 Targeting cells with altered microrna expression |
| 04/02/2008 | EP1903874A2 Aav vectors encoding superoxide dismutase |
| 04/02/2008 | EP1903872A2 Prevention of chronic rejection in solid organ transplantation |
| 04/02/2008 | EP1274729B1 G protein coupled receptor |
| 04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
| 04/02/2008 | EP1210357B1 Oligonucleotide n3'-p5' thiophosphoramidates: their synthesis and use |
| 04/02/2008 | EP1204761B1 Targeted artificial gene delivery |
| 04/02/2008 | EP0815245B1 Bioactive il-12 fusion proteins |
| 04/02/2008 | EP0666911B1 Multidrug resistance gene |
| 04/02/2008 | CN101155827A HIV resistance genes |
| 04/02/2008 | CN101155826A Replication-deficient rna viruses as vaccines |
| 04/02/2008 | CN101152576A Medicament for preventing and controlling alzheimer's disease |
| 04/02/2008 | CN101152575A Application of double-chain small disturbance RNA of PEG10 gene in preparing medicament for treating or preventing liver cancer |
| 04/02/2008 | CN100378219C Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/02/2008 | CN100378216C 9M-negative EHV-mutants |
| 04/02/2008 | CN100378124C Hsp70 from arthrobacter |
| 04/01/2008 | US7351818 Adjust efficiency translation of polypeptides; gene expression; vaccine; isolated Dna |
| 04/01/2008 | US7351813 Expression vector coding heterologous protein for use in human therapeutics; for treatment of blood nd liver disorders |
| 04/01/2008 | US7351792 G-protein coupled receptor for use as tool in identify modulators which prevent serine protease activation in response to trauma and immune system attack |